 |
|
|
|
 |
|
|
| Article 1 to 7 out of 7 concerning Kinaxo Biotechnologies GmbH
|
-
Kinaxo Biotechnologies Awarded Grant to Expand Applications for its Chemical Proteomics Platform
(07/28/2008)
Kinaxo Biotechnologies GmbH announced that it was awarded a 575,000 Euro grant by the Bavarian Ministry of Economic Affairs, Infrastructure, Transport and Technology to help expand the applications for its chemical proteomics platform. Chemical ...
-
KINAXO Biotechnologies Enters Agreement with Onconova Therapeutics Inc.
(05/15/2008)
KINAXO Biotechnologies announced a cooperation between Oncovova Therapeutics Inc, Newtown, PA, USA and KINAXO Biotechnologies. Onconova Therapeutics is a clinical stage research and development company focused on development of its novel small ...
-
Kinaxo Biotechnologies Enters Agreement with Takeda
(04/23/2008)
Kinaxo Biotechnologies announced that it has entered an agreement with Takeda San Diego, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Osaka, Japan. Under the agreement, Kinaxo will make its KinaTor(TM) technology ...
-
KINAXO Biotechnologies receives 1 million EUR funding to quantify drug interactions with cellular protein targets
(07/18/2007)
KINAXO Biotechnologies GmbH has received research funding of about EUR 1 million from the German Ministry for Education and Research (BMBF). This will enable KINAXO to establish a universally applicable technology platform to quantify small ...
-
KINAXO Announces Agreement with Johnson & Johnson Pharmaceutical Research & Development
(01/15/2007)
KINAXO Biotechnologies GmbH announced that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica. Under the agreement, KINAXO will use the KinaTorTM technology to ...
-
KINAXO announces agreement with UCB
(11/08/2006)
KINAXO Biotechnologies GmbH announced that it has entered into a services and collaboration agreement with UCB S.A. of Brussels, Belgium (UCB). Under the agreement, KINAXO will employ the KinaTorTM technology to perform selectivity analyses for ...
-
KINAXO enters into agreement with Schering AG on kinase inhibitor profiling
(07/31/2006)
KINAXO Biotechnologies GmbH has entered into a services and collaboration agreement with Schering AG. Under the agreement, KINAXO will employ the KinaTor(TM) technology to perform selectivity analyses for Schering AG's small molecule kinase ...
Additional information
Kinaxo Biotechnologies GmbH
Martinsried, Germany
Company
|
|
|
|
|
|
Top
